Stereotaxis (STXS) to Release Quarterly Earnings on Monday

Stereotaxis (NYSEAMERICAN:STXS - Get Free Report) is projected to release its Q1 2025 earnings data after the market closes on Monday, May 12th. Analysts expect Stereotaxis to post earnings of ($0.07) per share and revenue of $6.88 million for the quarter.

Stereotaxis Price Performance

NYSEAMERICAN STXS traded up $0.06 during trading hours on Wednesday, hitting $2.09. 202,912 shares of the company's stock traded hands, compared to its average volume of 369,096. The company has a market capitalization of $177.09 million, a PE ratio of -7.46 and a beta of 1.54. Stereotaxis has a 52-week low of $1.54 and a 52-week high of $2.72. The firm's 50-day moving average is $1.88 and its 200-day moving average is $2.07.

Insider Buying and Selling

In other news, Director Paul J. Isaac acquired 23,299 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were purchased at an average price of $1.81 per share, for a total transaction of $42,171.19. Following the acquisition, the director now owns 49,066 shares of the company's stock, valued at $88,809.46. This represents a 90.42 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 18.52% of the company's stock.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.